1Jefford M, Maraskovsky E, Cebon J, et al. The use of dendritic cells in cancer therapy. Lancet Oncol, 2001, 2(6) :343-353.
2Mailliard RB, Dallal RM, Son YI, et al. Dendritic cells promote T-cell survival or death depending upon their maturation state and presentation of antigen. Immunol Invest,2000, 29(2): 177-185.
3Schnurr M, Galambos P, Scholz C, et al. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines. Cancer Res, 2001, 61(17):6445-6450.
5Lindner M, Schirrmacher V. Tumour cell-dendritic cell fusion for cancer immunotherapy: comparison of therapeutic efficiency of polyethylen-glycol versus electro-fusion protocols. Eur J Clin Invest, 2002, 32(3):207-217.
6Heiser A, Coleman D, Dannull J, et al. Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors. JClinInvest, 2002, 109(3): 409-417.
7Kirk CJ, Mule JJ. Gene-modified dendritic cells for use in tumor vaccines. Hum Gene Ther, 2000, 11(6) : 797-806.
8Lau R, Wang F, Jeffery G, et al. Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanoma. J Immunother, 2001, 24(1): 66-78.
9O'Rourke MG, Johnson M, Lanagan C, et al. Durable complete clinical responses in a phase Ⅰ/Ⅱ trial using an autologous melanoma cell/dendritic cell vaccine. Cancer Immunol Immunother, 2003, 52(6): 387-395.
10Burch PA, Breen JK, Buckner JC, et al. Priming tissue-specific cellular immunity in a phase Ⅰ trial of autologous dendritic cells for prostate cancer. Clin Cancer Res, 2000,6(6): 2175-2182.
1Wan-Ping Chen, Xin He, Qi-Fa Ye and Ke Li Institute of Organ Transplantation, Third Xiangya Hospital, Xiangya Medical College, Central South University, Changsha 410013, China, and Institute of Clinical Pharmacology, Xiangya Medical College, Central South University, Changsha 410078, China.Implantation of a drug delivery system during surgery for patients with primary hepatocarcinoma[J].Hepatobiliary & Pancreatic Diseases International,2006,5(3):391-395. 被引量：2
5Banchereau J,Palucka AK,Dhodapkar M,et al.Immune and clinical responses in patients with metastatic melanoma to CD34 (+)progenitor-derived dendritic cell vaccine.Cancer Res 2001 ;61 (17):6451-6458
6David T,Akashi K,Markus M.development of CD8a-positive dendritic cells from a common myeloid progenitor.Science 2000;290(15):2152
7Palucka AK,Dhodapkar MV,Paczesny S,et al.Single injection of CD34+ progenitor-derived dendritic cell vaccine can lead to induction of T-cell immunity in patients with stage Ⅳ melanoma.J Immunother 2003;26 (5):432-439
8Inaba K,Inaba M,Romani N,et al.Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte macrophage colony stimulating factor.J Exp Med 1992;176(6):1693-1702
9Kenedy JE.High intensity focused ultrasound in the treatment of solid tumours.Nature Reviews Cancer 2005; 5(4):321-327
10CeluzziCM,Mayordomo JI,Storkus W J,et al.Peptide-pulsed dendritic cells induce antigen7specific,cytotoxic T lymvhocyte-mediated protective tumor immunity.J Exp Med 1996; 183 (1):283-287
